Climate Change Data

Abacus Medicine A/S

Climate Impact & Sustainability Data (2022, 2023)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:814.7 tCO2e (Scope 1 & 2)
Scope 1 Emissions:213.7 tCO2e
Scope 2 Emissions:601.3 tCO2e (market-based)
Renewable Energy Share:32%
Total Energy Consumption:2,425,815 kwh

ESG Focus Areas

  • Good Health and Well-being
  • Decent Work and Economic Growth
  • Responsible Consumption and Production

Environmental Achievements

  • Started test phase of a new plastic baler at the largest production site in Hungary to increase plastic waste recycling.
  • Took steps to recycle hazardous waste and are focusing on recycling electronic waste.
  • Introduced a new procurement policy requiring consideration of environmental impact for high-value procurements.

Social Achievements

  • Launched a Global Leadership Development program for 60 leaders.
  • Developed a Diversity & Inclusion strategy centered around conscious inclusion.
  • Implemented initiatives related to work-life integration and family friendliness, particularly in Hungary (parental leave framework, summer childcare program).

Governance Achievements

  • Continued work on Supplier Code of Conduct, including introduction of a new code for transporters.
  • Maintained a robust compliance framework, including a Whistleblowing Scheme.

Climate Goals & Targets

Medium-term Goals:
  • Achieve 40/60 gender representation in Board, EMT, and SMT by 2026.
Short-term Goals:
  • Implement Performance Management Process (Q1 2023).
  • Finalize global workshops for improved collaboration (Q1 2023).

Environmental Challenges

  • Environmental impact of transporting medicine (Scope 3 emissions).
  • Waste management from repackaging medicine.
  • Maintaining internal communication and collaboration with rapid growth.
Mitigation Strategies
  • Mapping the value chain to measure Scope 3 emissions from transportation.
  • Implementing a new plastic baler and improving hazardous waste recycling.
  • Global workshops for leaders and employees to improve communication and collaboration.

Supply Chain Management

Responsible Procurement
  • Supplier Code of Conduct for medicinal suppliers and transporters.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: Greenhouse Gas Protocol

UN Sustainable Development Goals

  • SDG 3
  • SDG 8
  • SDG 12

The company's business model contributes to better access to medicine (SDG 3), promotes decent work (SDG 8), and works towards responsible consumption and production (SDG 12).

Reporting Period: 2023

Environmental Metrics

Total Carbon Emissions:855.5 tCO2e (Scope 1 & 2)
Scope 1 Emissions:216.9 tCO2e
Scope 2 Emissions:632.9 tCO2e (location-based)
Renewable Energy Share:31%
Total Energy Consumption:2,449,906 kWh
Waste Generated:192 tons (Paper and Cardboard)

ESG Focus Areas

  • Good Health and Well-being (SDG 3)
  • Decent work and Economic Growth (SDG 8)
  • Responsible Consumption and Production (SDG 12)
  • Diversity & Inclusion
  • Environmental Impact (Transportation and Waste)
  • Governance (Compliance and Ethics)

Environmental Achievements

  • 91% of 192 tonnes of Paper and Cardboard waste was recycled in Hungary in 2023.
  • Successfully completed testing phase for a plastic baler in Hungary in 2023.
  • Rolled out a repurposing system in the largest production facility in Hungary in 2023 for materials such as wooden and plastic pallets, paper and plastic filling materials, and paper shipping boxes.

Social Achievements

  • 80% employee response rate in Employee Satisfaction Survey with a 3.2/4 score for engagement and commitment.
  • Implemented a new Performance Management Process in 2023.
  • Introduced a Global Mentor Programme in November 2023.
  • Continued collaboration workshops initiated in 2022.
  • Rolled out an inclusive leadership programme in 2023 for all managers.
  • Celebrated Diversity Month in 2023 with various activities.

Governance Achievements

  • Restructured the Sustainability Steering Committee (SSC) to ensure broader representation of business functions.
  • Introduced a Sustainable Procurement Policy in October 2023.
  • Board of Directors reviews Compliance Framework policies annually.

Climate Goals & Targets

Environmental Challenges

  • Medicine shortages in several European countries due to various factors (production capacity, distribution, compliance delays, market prioritization by manufacturers).
  • Environmental impact from transportation and repackaging of medicine.
  • Maintaining collaboration and internal communication with rapid growth.
Mitigation Strategies
  • Parallel import of medicines to address shortages.
  • Continuous improvement of transportation efficiency and exploration of sustainable alternatives.
  • Implementation of a highly effective waste management system.
  • Sustainable Procurement Policy.
  • Collaboration workshops to improve communication and collaboration.

Supply Chain Management

Responsible Procurement
  • Sustainable Procurement Policy
  • Supplier Code of Conduct for Medicinal Suppliers and Transporters

Climate-Related Risks & Opportunities

UN Sustainable Development Goals

  • SDG 3
  • SDG 8
  • SDG 12

Abacus Medicine's business model contributes to these goals through improved access to medicine, decent work practices, and responsible consumption and production.